ERBB2 and breast cancer: Notably, abnormalities in TC, LDL-C, HDL-C, and ApoA1 are more prevalent in the TNBC and human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtypes compared to the luminal subtype (27).